Abstract
Bioactive peptides produced by enzymatic hydrolysis of food-derived proteins could be used for various biomedical applications such as antihypertensive drugs. In the depicted study, a highly specific M. xanthus prolyl endopeptidase mutant was rationally designed by constraint/free molecular dynamics simulations and binding energy calculations towards the application in the hydrolysis of food-derived proteins to produce antihypertensive peptides with a proline C-terminus. More information can be found in the Research Article by J. Z. H. Zhang, L. Zhang, et al.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
